ST. PETERSBURG, FL, Nov. 5, 2014 (GLOBE NEWSWIRE) -- FutureWorld Corp. (OTCQB;FWDG), a leading provider of advanced technologies and solutions to the global cannabis industry, announces that it has purchased controlling ownership interest in provisional patent #61/977,514, for Onsite Cannabis THC Potency Test Kit, from Angela Knittel, CEO of WMII Inc. Mrs. Knittel and her partners developed a similar process for THC potency and applied for a provisional patent covering and protecting the process. With the purchase of their controlling interest in the provisional patent #61/977,514, CB Scientific has become global leader in Cannabis personal THC and CBD analytics. The Company is also in the process of filing provisional patents for its own developed THC and CBD analytics, strengthening its position as the first mover and the global leader in cannabis personal analytics.
Knittel and her company WMII, Inc. (Worldwide Marijuana
Community) has also agreed to become a distribution representative
marketing the PersonalAnalytics THC & CBD Test Kits on behalf
of CB Scientific, a wholly-owned subsidiary of FutureWorld Corp. CB
Scientific expects to sell thousands of the PersonalAnalytics THC
& CBD PocketLabs by the end of 2014 and hundreds of thousands
by the end of 2015.
"Bringing on Ms. Knittel and her company, Worldwide Marijuana
Community, as a distribution representative only strengthens CB
Scientific and FutureWorld Corp. We believe the purchase of Ms.
Knittel's intellectual property helps our company to strengthen its
position as the market leader of 'on the spot' potency testing of
cannabis." said CEO of CB Scientific, Bill Short.
The recent local and national media exposure received by CB Scientific and FutureWorld for its unique invention of PersonalAnalytics, the 1st Ever Affordable Home Testing Kits for THC and CBD, has helped bolster the company's position in the eyes of medical cannabis patients and growers worldwide. CB Scientific has had requests for its PersonalAnalytics "PocketLabs" from as far away as Australia.
A recent review of the Test Kits by HIGH TIMES Magazine has also shown the kits to be highly accurate and effective in helping patients and growers to know potency levels of THC and CBD in their crops and medicine.
http://www.hightimes.com/read/high-buy-cbscientific-personal-analytics-thc-and-cbd-test-kit
The super quick 'on the spot' results of PersonalAnalytics THC & CBD Test Kits are an effective intermediary between "nothing or no testing" and "expensive labs" that can take days to get reports; reports Hightimes magazine.
ABOUT CB SCIENTIFIC
CB Scientific (http://www.cbscientific.com) is a wholly owned company based in Denver Colorado. CB Scientific is continuing to develop new technologies specifically for cannabis analytics. Senior management team includes Charlie Steinberg and Derek Lebahn. Mr. Steinburg and Mr. Lebahn are some of the primary men advancing gas chromatography testing in Colorado. Mr. Steinburg has also pioneered residual solvent testing for medical cannabis and has always strived to help patients know exactly what they are buying. CB Scientific believes every product sold to patients as "Medical Quality" should be inspected for health benefits, safety, consistency, purity, potency and packaged properly for distribution.
Senior management team of CB Scientific have worked with many of the cannabis industry leaders in Colorado and have also been featured in cannabis industry publications including High Times Magazine, many trade publications, on-air interviews and panel discussions across the United States.
CB Scientific's focus has been the education and safety of consumers combined with innovation to put power into the hands of the patients. Values that FutureWorld is pleased to embrace while ever striving to raise the bar of cannabis analytics even higher.
ABOUT FUTUREWORLD CORP.
FutureWorld (Other OTCQB: FWDG), a Delaware corporation, is a U.S. Diversified Holding Company formed to capitalize on the burgeoning Cannabis markets globally. FutureWorld, together with its subsidiaries, focuses on the identification, acquisition, development, and commercialization of cannabis related products, such as industrial Hemp. FutureWorld, through its subsidiaries such as HempTech and CB Scientific, provides personal and professional THC and CBD test kits, pure CBD oil solutions, smart sensor technology, communication network, surveillance security, data analysis for smart cultivation and consultation for the industrial hemp and legal medicinal cannabis. Our wireless agricultural smart sensor networks offer precision to the agriculture, irrigation systems, and greenhouses for the global cannabis and hemp industry. FutureWorld and its subsidiaries do not grow, distribute or sell marijuana. To request further information about FutureWorld, please email us at info@futureworldcorp.com, log onto our website at http://www.futureworldcorp.com or visit us at our Facebook page https://www.facebook.com/futureworldenergy or on Twitter #futureworldinc.
Forward-Looking Statements
This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets. This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.